2001
DOI: 10.1006/exnr.2001.7652
|View full text |Cite
|
Sign up to set email alerts
|

Clostridium perfringens Prototoxin-Induced Alteration of Endothelial Barrier Antigen (EBA) Immunoreactivity at the Blood–Brain Barrier (BBB)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
42
0
1

Year Published

2002
2002
2018
2018

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(46 citation statements)
references
References 29 publications
3
42
0
1
Order By: Relevance
“…8 D-I ), which is in agreement with previous findings of sparse EBA-negative vessels in normal animals (Nishigaya et al, 2000;Zhu et al, 2001). In contrast, dyskinetic animals displayed a visible reduction of EBA expression in several areas.…”
Section: The Bbb Is Defective In Dyskinetic Animalssupporting
confidence: 91%
See 2 more Smart Citations
“…8 D-I ), which is in agreement with previous findings of sparse EBA-negative vessels in normal animals (Nishigaya et al, 2000;Zhu et al, 2001). In contrast, dyskinetic animals displayed a visible reduction of EBA expression in several areas.…”
Section: The Bbb Is Defective In Dyskinetic Animalssupporting
confidence: 91%
“…Weak or absent EBA staining is considered as a marker of BBB disruption (Sternberger et al, 1989;Nishigaya et al, 2000;Zhu et al, 2001). Studies addressing the time course of EBA expression after brain injury have shown that its downregulation precedes neovessel formation and that reexpression of the EBA antigen occurs within a narrow time window (Rosenstein et al, 1992;Nishigaya et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Endothelial barrier antigen (EBA), recognized by SMI-71 monoclonal antibodies (Sternberger Inc.), is a specific marker of the cerebral capillary barrier endothelium [7,15]. The expression of EBA is in high correlation with functional integrity of the blood-brain barrier (BBB) and is disordered in diseases associated with BBB impairment [9,11,16,22].…”
mentioning
confidence: 99%
“…This toxin accumulates mainly in the brain and kidneys when intravenously injected into rats (14), causing injury to neuronal cells (15)(16)(17) and cerebral blood vessels (18). One characteristic feature of the toxin is its extraordinarily high potency; 20 ng of ET kills a mouse within 1 h. 2 We have previously shown that proteolytic activation of ⑀-protoxin (ProET) is due to the removal of a C-terminal peptide (19,20) and that activated ET forms a heptamer in rat synaptosomal membranes (20).…”
mentioning
confidence: 99%